Tuesday, April 19, 2022 from 6:00 PM to 8:00 PM EDT


Capital City Country Club, 1601 Golf Terrace Drive 

Rosalie Carlin, Capital Medical Society
850-877-9018    rcarlin@capmed.org

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Florida Medical Association and Capital Medical Society.  The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Florida Medical Association designates this live activity for a maximum of
one (1.0) AMA PRA Category 1 Credits
Physicians should claim only the credit
commensurate with the extent of their participation in the activity.





























The advances in cardiothoracic surgery have been outstanding over the last 100 years from the 1st successful pneumonectomy in 1933 to the 1st cardiopulmonary bypass in the 1953.  Technology is advancing a very rapid rate in both cardiac and thoracic surgery.  Cardiac surgery embraces minimally invasive surgeries, percutaneous treatment of valvular disorders, and percutaneous aortic interventions.  In the thoracic realm advances in surgical intervention and diagnostics is a constantly involving door.  The impact on surgical and medical treatment includes better diagnostic modalities, less invasive procedures, safer procedures, faster recovery improved medical therapies.  Given the broad scope of advancement the in medical therapy and surgical interventions of cardiac in thoracic surgery today we will be discussing advances in minimally invasive thoracic surgery.

The planners of this activity disclosed no financial relationships with ineligible companies whose primarybusiness is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients,with the exception of Winston Ortiz, M.D. Dr. Ortiz disclosed that he is member of the speaker’s bureau for Allergan and TEVA.
Dr. Juan Gallegos, speaker for this educational event, has no relevant financial relationships with ineligible
companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.

Registration Deadline:  April 11, 2022
Dinner Included

Learning Objectives:
Described the oral of a multidisciplinary team.
Review diagnosis staging and management of lung cancer.
Described in compare surgical options for lung cancer.
Discussed non systemic and systemic therapy for lung cancer.